Stejskal, Reynolds, and Bjørklund examined the frequency of metal allergy in 38 patients with connective tissue disorders (1). Of these patients, 16 had rheumatoid arthritis, 13 had Sjögren’s syndrome, and nine had systemic lupus erythematosus. A control group of 43 healthy age and sex-matched subjects were included in the study. Metal allergy was evaluated using the optimized lymphocyte transformation test MELISA. For all subjects, the primary source of metal exposure was dental metal restorations. Most of the tested patients (87%) reacted to at least one metal, and many (63%) reacted to two or more of the tested metals. 43% of the healthy subjects in the study reacted to one metal, and 18% reacted to two or more metals. The increased frequency of metal allergy in the patient group compared with the control group was statistically significant (P < 0.0001). The most frequent allergens in the study were nickel, mercury, gold, and palladium.

Vera Stejskal is Associate Professor of Immunology at University of Stockholm, Sweden. She is founder and president of the MELISA Medica Foundation. Tim Reynolds is Professor of Clinical Biochemistry at the University of Wolverhampton, and a consultant chemical pathologist working at Burton Hospitals NHS Foundation Trust, Burton upon Trent, United Kingdom. Geir Bjørklund is founder and president of the Council for Nutritional and Environmental Medicine (CONEM).

Stejskal, Öckert, and Bjørklund studied the frequency and clinical relevance of metal allergy in 15 fibromylagia (FM) patients (1). Metal allergy was measured by a lymphocyte transformation test, MELISA®. Ten healthy age matched women were used as controls. Reduction of metal exposure in the FM patients was achieved by replacement of dental metal restorations and by the avoidance of known sources of metal exposure. Objective health assessment was performed 5 years after treatment. Subjective health assessment was established by a questionnaire, completed 2, 5 and in some cases 10 years after the start of the study. Follow-up MELISA was also performed. All FM patients tested positive to at least one of the metals tested. Objective examination 5 years later showed that half of the patients no longer fulfilled the FM diagnosis, 20% had improved and the remaining 30% still had FM. All patients reported subjective health improvement.

Vera Stejskal is Associate Professor of Immunology at University of Stockholm, Sweden. She is founder and president of the MELISA Medica Foundation. Karin Öckert is a pensioned Swedish dentist/specialist in periodontics. Geir Bjørklund is founder and president of the Council for Nutritional and Environmental Medicine (CONEM).

Vera Stejskal, PhD is Associate Professor of Immunology at University of Stockholm, Sweden. She is founder and president of the MELISA Medica Foundation. Stejskal discusses in a recent editorial article in the Israel Medical Association Journal (IMAJ) how, despite widespread exposure to metals, only a minority of people develop allergic and autoimmune disorders such as ASIA syndrome (1). In order to protect these individuals, identifying clinical and laboratory markers of susceptibility is key. Mercury and other metals can be added to the list of environmental agents that contribute to ASIA syndrome. Together with screening for autoantibodies, metal-specific T cells can be used to identify at-risk individuals. Dr. Stejskal is a CONEM member.

Vera Stejskal, Ph.D. is Associate Professor of Immunology at University of Stockholm, Sweden. She is founder and preident of the MELISA® MEDICA Foundation, which is dedicated to the science of metal allergy and its diagnosis when treating chronic diseases such as chronic fatigue syndrome/myalgic encephalopathy (CFS /ME), multiple sclerosis (MS) or other autoimmune and allergic diseases. She is also a CONEM member.

The MELISA® test, invented by Dr. Stejskal, is the only scientifically-proven blood test which diagnoses metal allergy to multiple metals. Further test applications include the diagnosis of Lyme disease. In this lecture, Vera Stejskal talks about MELISA® testing to diagnose and treat metal-induced diseases and conditions. The lecture was held in September 2008 at IAOMT Annual Meeting in Charlotte, North Carolina.